To reduce the risk of a positive test, athletes should follow the minimum washout periods recommended by WADA
However, research on this pentadecapeptide is primarily animal-based and in vitro , with no published full-text clinical studies despite some authors mentioning a phase 1 trial on BPC-157 as an anti-ulcerative agent in IBD patients [6]
Given widespread, unofficial use, reporting appears limited
The investigators reported reduced cumulative body-weight gain relative to control animals and increased lipolytic activity in isolated adipose tissue obtained from AOD9604-exposed animals
Absorption is reliable and dosing is precise
Contaminated products risk infection, allergic reactions, and administration of unknown substances